Mutated EGFR kinase domain in complex with gefitinib. en Crystal structure of the mutated EGFR kinase domain GS in complex with gefitinib The residue GS is shown in red and the residue TM in yellow small molecule tyrosine kinase inhibitor chlorofluorophenyl methoxy morpholinylpropoxy quinazolinamine or etinib is shown as strick This